Halozyme Therapeutics | HALO - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Baxter International USD 1.09B 87M 2026-03
Cara Therapeutics USD 3.22M 859K 2025-12
Cytokinetics USD 24.71M 80.91M 2026-03
DBV Technologies USD 39.82M 972K 2025-09
Eli Lilly USD 5.03B 350M 2026-03
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
MannKind USD 16.14M 7.11M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Pfizer USD 4.51B 734M 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
United Therapeutics USD 498.3M 491.2M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12